Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Transgenomic logo — company profile

Transgenomic

Founded 1997 United States United States 42 employees

General Information

Company Name Transgenomic
Founded Year 1997
Location United States United States
Employees 42
Social

Get notified when Transgenomic moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Transgenomic

Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products, including its flagship C-GAAP test, designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events. Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.

No funding data available for Transgenomic yet.

Get notified when Transgenomic raises funding

Transgenomic Alternatives & Competitors

Transgenomic vs
Positron Corporation
Positron Corporation United States

Positron Corporation is a medical technology company that co-develops, manufactures, and sells state...

Post Ipo Equity
28 employees
Biotechnology, Health Care
Transgenomic vs
Invivoscribe
Invivoscribe United States

Improving Lives with Precision Diagnostics®

199 employees
Biotechnology, Health Care
Transgenomic vs
Biocartis
Biocartis Belgium

High precision diagnostics for personalized medicine

Grant
315 employees
Biotechnology, Health Care

FAQ About Transgenomic

Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genet...
Transgenomic was founded in 1997.
Transgenomic is headquartered in United States.
Transgenomic has approximately 42 employees.
Top alternatives and competitors to Transgenomic include Positron Corporation, Invivoscribe, Biocartis, Celprogen, Inc, Sun Radiology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Transgenomic and Positron Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Transgenomic and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy